Intravenous treatment of migraine

Techniques in Regional Anesthesia and Pain Management

Volumn 16, Issue 1, 2012, Pages 25-29

  Ashina, Sait ^a,b   Portenoy, Russell K ^a,b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Headache; Infusion; Intravenous; Migraine; Treatment

Indexed keywords

BENZATROPINE; CHLORPROMAZINE; DEXAMETHASONE; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; FENTANYL; GLUCOCORTICOID; HYDROMORPHONE; IBUPROFEN; KETOROLAC; MAGNESIUM; MAGNESIUM SULFATE; METOCLOPRAMIDE; MORPHINE; PARACETAMOL; PLACEBO; PROCHLORPERAZINE; SODIUM CHLORIDE; SUMATRIPTAN; VALPROIC ACID;

AKATHISIA; ARTICLE; CHRONIC DAILY HEADACHE; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DYSTONIA; ELECTROCARDIOGRAPHY; EMERGENCY WARD; FLUID RETENTION; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY FUNCTION; MIGRAINE; MIGRAINE WITH AURA; NAUSEA AND VOMITING; ORTHOSTATIC HYPOTENSION; PAIN ASSESSMENT; PARKINSONISM; QT PROLONGATION; RECOMMENDED DRUG DOSE; RISK BENEFIT ANALYSIS; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE;

EID: 84873186009     PISSN: 1084208X     EISSN: 15584534     Source Type: Journal    
DOI: 10.1053/j.trap.2012.11.004     Document Type: Article

References (47)

1. Lipton R.B., Stewart W.F., Diamond S., et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646-657.
2. Goadsby P.J., Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 2010, 9:285-298.
3. Goldstein J.N., Camargo C.A., Pelletier A.J., et al. Headache in United States emergency departments: demographics, work-up and frequency of pathological diagnoses. Cephalalgia 2006, 26:684-690.
4. Paemeleire K., Crevits L., Goadsby P.J., et al. Practical management of medication-overuse headache. Acta Neurol Belg 2006, 106:43-51.
5. Krusz J.C. Intravenous treatment of chronic daily headaches in the outpatient headache clinic. Curr Pain Headache Rep 2006, 10:47-53.
6. Friedman B.W., Grosberg B.M. Diagnosis and management of the primary headache disorders in the emergency department setting. Emerg Med Clin North Am 2009, 27:71-87.
7. Saper J.R. Pearls from an inpatient headache unit. Headache 2008, 48:820-827.
8. Fanciullacci M., Alessandri M., Del R.A. Dopamine involvement in the migraine attack. Funct Neurol 2000, 15(suppl 3):171-181.
9. Taylor B.K., Joshi C., Uppal H. Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 2003, 987:135-143.
10. Ellis G.L., Delaney J., DeHart D.A., et al. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med 1993, 22:191-195.
11. Tek D.S., McClellan D.S., Olshaker J.S., et al. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990, 19:1083-1087.
12. Friedman B.W., Corbo J., Lipton R.B., et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 2005, 64:463-468.
13. Coppola M., Yealy D.M., Leibold R.A. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 1995, 26:541-546.
14. Bigal M.E., Bordini C.A., Speciali J.G. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med 2002, 23:141-148.
15. Bell R., Montoya D., Shuaib A., et al. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990, 19:1079-1082.
16. Silberstein S.D., Young W.B., Mendizabal J.E., et al. Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial. Neurology 2003, 60:315-321.
17. Wang S.J., Silberstein S.D., Young W.B. Droperidol treatment of status migrainosus and refractory migraine. Headache 1997, 37:377-382.
18. Siow H.C., Young W.B., Silberstein S.D. Neuroleptics in headache. Headache 2005, 45:358-371.
19. Lake C.R., Casey D.E., McEvoy J.P., et al. Anticholinergic prophylaxis in young adults treated with neuroleptic drugs. Psychopharmacol Bull 1986, 22:981-984.
20. Vinson D.R., Drotts D.L. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. Ann Emerg Med 2001, 37:125-131.
21. Silberstein S.D., McCrory D.C. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache 2003, 43:144-166.
22. Callaham M., Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986, 26:168-171.
23. Klapper J.A., Stanton J. The emergency treatment of acute migraine headache: a comparison of intravenous dihydroergotamine, dexamethasone, and placebo. Cephalalgia 1991, 11(suppl 11):159-160.
24. Raskin N.H. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986, 36:995-997.
25. Robbins L., Remmes A. Outpatient repetitive intravenous dihydroergotamine. Headache 1992, 32:455-458.
26. Nagy A.J., Gandhi S., Bhola R., et al. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology 2011, 77:1827-1832.
27. Saper J.R., Silberstein S. Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. Headache 2006, 46(suppl 4):S171-S181.
28. Robertson C.E., Black D.F., Swanson J.W. Management of migraine headache in the emergency department. Semin Neurol 2010, 30:201-211.
29. Liu H.T., Hollmann M.W., Liu W.H., et al. Modulation of NMDA receptor function by ketamine and magnesium: Part I. Anesth Analg 2001, 92:1173-1181.
30. Vikelis M., Mitsikostas D.D. The role of glutamate and its receptors in migraine. CNS Neurol Disord Drug Targets 2007, 6:251-257.
31. Eide P.K. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain 2000, 4:5-15.
32. Mauskop A., Altura B.M. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 1998, 5:24-27.
33. Bigal M.E., Bordini C.A., Tepper S.J., et al. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 2002, 22:345-353.
34. Demirkaya S., Vural O., Dora B., et al. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 2001, 41:171-177.
35. Cete Y., Dora B., Ertan C., et al. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia 2005, 25:199-204.
36. Corbo J., Esses D., Bijur P.E., et al. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med 2001, 38:621-627.
37. Edwards K.R., Norton J., Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 2001, 41:976-980.
38. Mathew N.T., Kailasam J., Meadors L., et al. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 2000, 40:720-723.
39. Tanen D.A., Miller S., French T., et al. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med 2003, 41:847-853.
40. Baden E.Y., Hunter C.J. Intravenous dexamethasone to prevent the recurrence of benign headache after discharge from the emergency department: a randomized, double-blind, placebo-controlled clinical trial. CJEM 2006, 8:393-400.
41. Rowe B.H., Colman I., Edmonds M.L., et al. Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache. Headache 2008, 48:333-340.
42. Colman I., Friedman B.W., Brown M.D., et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. Br Med J 2008, 336:1359-1361.
43. Singh A., Alter H.J., Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature. Acad Emerg Med 2008, 15:1223-1233.
44. Robertson C.E., Black D.F., Swanson J.W. Management of migraine headache in the emergency department. Semin Neurol 2010, 30:201-211.
45. Shrestha M., Singh R., Moreden J., et al. Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial. Arch Intern Med 1996, 156:1725-1728.
46. Seim M.B., March J.A., Dunn K.A. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med 1998, 5:573-576.
47. Meredith J.T., Wait S., Brewer K.L. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med 2003, 21:173-175.